(Q37529635)

20 August 2017

Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery (English)

1 reference

20 August 2017

1 reference

1 reference

6

David J Sugarbaker

1 reference

20 August 2017

8

Pasi A Jänne

1 reference

20 August 2017

3

Megan Othus

1 reference

20 August 2017

2

Elizabeth H Baldini

1 reference

20 August 2017

Hale B Caglar

1

1 reference

20 August 2017

Michael S Rabin

4

1 reference

20 August 2017

Raphael Bueno

5

1 reference

20 August 2017

Steven J Mentzer

7

1 reference

20 August 2017

Bruce E Johnson

9

1 reference

20 August 2017

Aaron M Allen

10

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

20 August 2017

1 reference

20 August 2017

115

1 reference

20 August 2017

4156-4166

1 reference

20 August 2017

18

1 reference

Potential for reduced toxicity and dose escalation in the treatment of inoperable non–small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation

20 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

The long-term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24492

7 January 2021

Identifiers

DOI

10.1002/CNCR.24492

1 reference

20 August 2017

1 reference